Precept Management LLC Uni Qure N.V. Transaction History

Precept Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $1.06 Million - $1.52 Million	-30,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $539,700 - $714,900	-15,000 Reduced 33.33%	30,000 $1.11 Million
Q2 2020 Aug 14, 2020	SELL	$45.06 - $67.74 $450,600 - $677,400	-10,000 Reduced 18.18%	45,000 $2.03 Million
Q1 2020 May 15, 2020	BUY	$40.01 - $73.97 $1.2 Million - $2.22 Million	30,000 Added 120.0%	55,000 $2.61 Million
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $928,250 - $1.87 Million	25,000 New	25,000 $1.79 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Precept Management LLC, based on Form 13F filings with the SEC.

Stay updated on Precept Management LLC with notifications on news.